Congress finds the following:
(1)
Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are a group of man-made chemicals that have been used in a wide range of products since the 1940s including firefighting foam, carpeting, packaging, and cookware. There are more than 5,000 types of registered PFAS compounds. This chemical class is not currently regulated at the Federal level.
(2)
changed
PFAS have been detected in air, water, soil, food, biosolids, and more. They can accumulate and remain in the body for a long time, and can potentially lead to serious health effects including cancer, low infant birthweight, liver and kidney issues, reproductive and developmental problems, and more.
(3)
There remains much unknown about PFAS toxicity, human and environmental health effects, exposure pathways, as well as effective removal, treatment, and destruction methods, and safe alternatives to PFAS.
(4)
changed
There is currently no cohesive, interagency effort to address PFAS, and no Federal agency is focused on a multidisciplinary, cross-sector approach. Rather, there are fragmented research efforts have been fragmented at various agencies that have failed and struggled to effectively address the full scope of challenges presented by PFAS.
(5)
changed
Regulatory action and cleanup depend on scientific analysis of toxicity data, decision making on how best to deal with the thousands of PFAS, and understanding the significance of the many exposure pathways that exist. A consensus study by the National Academies of Sciences, Engineering, and Medicine would help inform decisions by Federal and State Governments, industry, and other stakeholders on how to best address PFAS.
Sec. 3
National Academies reports
(a)
changed
Research assessments of PFAS exposure and toxicity—PFAS—
(1)
changed
In General—general— Not later than 90 days after the date of enactment of this Act, the Administrator of the Environmental Protection Agency, in consultation with the Director of the National Science Foundation, the Secretary of Defense, the Director of the National Institutes of Health, and other Federal agencies with expertise relevant to understanding PFAS exposure exposure, behavior, and toxicity, shall enter into an agreement with the National Academies to conduct a two-phase study and submit reports a report in accordance with this subsection to further address research and knowledge gaps identified by the Federal Government Human Health PFAS Research Workshop held on October 26 and 27, 2020, and identify research and development needed to advance human exposure estimation and toxicity identify, categorize, evaluate, and hazard estimation of address individual or total PFAS.
(2)
changed
Phase I study Study and report on human exposure estimation—
(A)
changed
In general— The phase I study required to be conducted under paragraph (1) shall, at a minimum—
(i)
changed
consider life-cycle information on the manufacture, use, and disposal of PFAS-containing products to identify potential human exposure sources sources, including occupational exposures, and potential exposure pathways for the public;
(ii)
evaluate the fate and transport of PFAS and their breakdown products;
(iii)
changed
if feasible, estimate human exposure to individual or total PFAS to determine relative source contributions for various exposure pathways (such as air, water, soil, or food);
(iv)
changed
determine environmentally relevant PFAS; andthe range of solubility, stability, and volatility of PFAS most likely to be found in the environment and the resulting prevalence in animals and humans;
(v)
changed
identify research needed to advance exposure estimation give consideration as to individual or total PFAS.whether chemical category-based approaches would be appropriate for evaluating PFAS toxicity and exposure;
(vi)
added
identify research needed to advance exposure estimation to individual or total PFAS; and
(B)
removed
Report— Not later than 270 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in subparagraph (A) and shall make such report available on a publicly accessible website.
(3)
removed
Phase II study and report on PFAS toxicity and hazard estimation—
(A)
removed
In general— The phase II study required to be conducted under paragraph (1) shall, at a minimum—
(i)
removed
review animal and human toxicity information on the environmentally relevant PFAS identified in the Phase I report under paragraph (2) and develop an approach for conducting a hazard assessment of these PFAS;
(ii)
removed
give consideration as to whether chemical category-based approaches for assessing toxicity would be appropriate for evaluating PFAS as a group; and
(vii)
renumbered
was (2)(4)(2)(5)
identify research needed to advance toxicity and hazard assessment of individual or total PFAS.
(B)
added
Report— Not later than 540 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in subparagraph (A) and shall make such report available on a publicly accessible website.
(B)
removed
Report— Not later than 270 days after the date on which the Phase I report is submitted to Congress under paragraph (2), the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in subparagraph (A) and shall make such report available on a publicly accessible website.
(b)
Research assessment of management and treatment alternatives for PFAS contamination in the environment—
(1)
changed
In General—general— Not later than 90 days after the date of enactment of this Act, the Administrator of the Environmental Protection Agency and the Director of the National Science Foundation, in consultation with the Secretary of Defense and other Federal agencies with expertise relevant to the development of PFAS alternatives and the management and treatment of PFAS, shall jointly enter into an agreement with the National Academies to conduct a study and submit a report in accordance with this subsection to better understand the research and development needed to advance the understanding of the extent and implications of human and environmental contamination by PFAS, how to manage and treat such contamination, and the development of safe alternatives.
(2)
Scope of study— The study described in paragraph (1) shall, at a minimum, include the following:
(A)
changed
An assessment of the current research on such issues.best available strategies for PFAS treatment, site remediation, and safe disposal, including demonstration or pilot projects related to destruction methods and alternative materials or tools for firefighters.
(B)
changed
A description of the research gaps relating to such issues.issues, including consideration of emerging or future PFAS and potential classification methods.
(C)
changed
Recommendations on how the Federal Government can best address the research needs identified pursuant to subparagraph (B).(B) through increased collaboration or coordination of existing and new programs.
(D)
Recommendations on how research can best incorporate considerations of socioeconomic issues into the development of research proposals and the conduct of research.
(3)
Report— Not later than 540 days after the date on which the agreement described in paragraph (1) is finalized, the National Academies shall submit to Congress a report containing the findings and recommendations of the study described in paragraph (2) and shall make such report available on a publicly accessible website.
(c)
changed
Authorization of Appropriations—appropriations— There is authorized to be appropriated $3,000,000 to the Administrator of the Environmental Protection Agency to carry out this section—section.
(1)
removed
to the Administrator of Environmental Protection Agency, $3,000,000; and
(2)
removed
to the Director of the National Science Foundation, $1,000,000.